References
- Adamson JW, Fialkow PJ, Murphy S, Prchal JF, Steinmann L. Polycythemia vera: stem cell and probable clonal origin of the disease. N Engl J Med 1976; 295: 913–916
- Landaw SA. Acute leukemia in polycythemia vera. Sem Hematol 1986; 23: 156–165
- Najean Y, Rain JD. Treatment of polycythemia vera: use of 32P alone or in combination with maintenance therapy using hydroxyurea in 461 patients greater than 65 years of age. Blood 1997; 89: 2319–2327
- Cervantes F, Tassies D, Salgado C, Rovira M, Pereira A, Rozman C. Acute transformation in nonleukemic chronic myeloproliferative disorders: actuarial probability and main characteristics in a series of 218 patients. Acta Haematol 1991; 85: 124–127
- Hernández JM, Orfao A, González M, Cuesta B, López-Berges MC, Cañizo MC, Ciudad J, San Miguel JF. Immunophenotypic characterisation of acute leukaemia after polycythemia vera. J Clin Pathol 1993; 46: 668–671
- Hoffman R, Estren S, Kopel S, Marks SM, McCaffrey RP. Lymphoblastic-like leukaemia transformation of polycythemia vera. Ann Intern Med 1978; 89: 71
- Braich TA, Grogan TM, Hicks MJ, Greenberg BR. Terminal lymphoblastic transformation in polycythemia vera. Am J Med 1986; 80: 304–306
- Aitchison R, Black AJ, Greaves MF. Polycythemia rubra vera transforming to acute lymphoblastic leukaemia. Clin Lab Haematol 1987; 9: 201–204
- Anastasi J, Pettenati MJ, Le Beau MM, Kwaan HC, Weil SC. Acute lymphoblastic leukemia in a patient with longstanding polycythemia vera: cytogenetic analysis reveals two distinct abnormal clones. Am J Hematol 1988; 29: 33–37
- Neilson JR, Patton WN, Williams MD, Mayne EE, Boughton BJ. Polycythaemia rubra vera transforming to acute lymphoblastic leukaemia with a common immunophenotype. J Clin Pathol 1994; 47: 471–472
- Arai Y, Masuda M, Okamura T, Wada M, Motoji T, Mizoguchi H. Polycythemia vera progressing to acute lymphoblastic leukemia after 13 years. Rinsho Ketsueki 1996; 37: 1405–1409, (English abstract)
- Berlin N. Diagnosis and classification of the polycythemias. Semin Hematol 1975; 12: 339–351
- Bene MC, Castoldi G, Knapp W, Ludwig WD, Matutes E, Orfao A, van't Veer MB. Proposal for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL). Leukemia 1995; 9: 1783–1786
- Bennett JM, Catovsky D, Daniel MT, et al. Proposal for the classification of the acute leukemias. Brit J Haematol 1976; 33: 451–458
- Messinezy M, Pearson TC, Prochazka A, Whetherley-Mein G. Treatment of proliferative polycythaemia by venesection and low-dose busulphan: retrospective study from one centre. Brit J Haematol 1985; 61: 657–666
- Najean Y, Rain JD. Treatment of polycythemia vera: the use of hydroxyurea and pipobroman in 292 patients under the age of 65 years. Blood 1997; 9: 3370–3377
- Jacobsen N, Theilade K, Videbaek A. Two additional cases of coexisting polycythaemia vera and chronic lymphocytic leukaemia. Scand J Haematol 1982; 29: 405–410
- Steinberg E, Ben-Dor D, Lugassy G. Anaplastic B-cell (Ki-1) lymphoma developing in a patient with polycythemia vera. Leukemia and Lymphoma 1995; 19: 507–509
- Fink L, Bauer F, Perry JJ. Coincidental polycythemia vera and multiple myeloma: case report and review. Am J Hematol 1993; 44: 196–200
- Raskind WH, Jacobson R, Murphy S, Adamson JW, Fialkow PJ. Evidence for the involvement of B-lymphoid cells in polycythemia vera and essential thrombocythemia. J Clin Invest 1985; 75: 1388–1390